Reduced-dose WBRT combined with SRS for 1–4 brain metastases aiming at minimizing neurocognitive function deterioration without compromising brain tumor control
Author(s) -
Toshimichi Nakano,
Hidefumi Aoyama,
Shunsuke Onodera,
Hiroshi Igaki,
Yasuo Matsumoto,
Ayae Kanemoto,
Shigetoshi Shimamoto,
Masayuki Matsuo,
Hidekazu Tanaka,
Natsuo Oya,
Tomohiko Matsuyama,
Atsushi Ohta,
Katsuya Maruyama,
Takahiro Tanaka,
Nobutaka Kitamura,
Kohei Akazawa,
Katsuya Maebayashi
Publication year - 2022
Publication title -
clinical and translational radiation oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.336
H-Index - 15
ISSN - 2405-6308
DOI - 10.1016/j.ctro.2022.09.005
Subject(s) - neurocognitive , medicine , brain function , brain tumor , pathology , cognition , neuroscience , psychiatry , psychology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom